Genmab — Februar 2024
-
I thought yesterday Pagano would sell the shares from his warrant excercise, since he exercised them so early before expiration date. As he doesn’t seem to have sold them, I am now thinking he did it for tax planning? He seems the kind of guy to think carefully about that.
-
If you are bullish on the stock, it pays to exercise early in the US if the share price is low i think; he now pays income tax ‘only’ on [+-2000 dkk – the exercise price] (@ +-45%) and if he can sell it higher later, he will pay capital gains tax on that gain from 2000. ( @20%).
-
-
-
Ordesekimab (AMG 714/PRV-015)
or whatever you want to call it, has completed enrollment. Hopefully some data end summer? https://classic.clinicaltrials.gov/ct2/history/NCT04424927?B=23&A=22&C=merged#StudyPageTop -
Kort video.."Sidst, men ikke mindst omtales smertensbarnet Genmab, som muligvis oplever et bullrun efter en teknisk bundvending". https://www.proinvestor.com/boards/119050/
-
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons https://www.proinvestor.com/investornyt/1125177/transactions-with-shares-and-linked-securities-in-genmab-a-s-made-by-managerial-employees-and-their-closely-associated-persons
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind